Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ferroheme i + H2O + acceptor
hydroxyferroheme i + reduced acceptor
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
ferroheme o + H2O + acceptor
ferroheme i + reduced acceptor
ferroheme i + H2O + acceptor

hydroxyferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
ferroheme i + H2O + acceptor
hydroxyferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
ferroheme o + H2O + 2 acceptor

ferroheme a + 2 reduced acceptor
overall reaction
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + acceptor

ferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
ferroheme o + H2O + acceptor
ferroheme i + reduced acceptor
the enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
ferroheme o + H2O + 2 acceptor

ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
ferroheme o + H2O + 2 acceptor
ferroheme a + 2 reduced acceptor
overall reaction. The enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Brain Diseases
Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome.
Cardiomyopathies
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency.
Cardiomyopathy, Hypertrophic
Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into its Function in Eukaryotes.
Cardiomyopathy, Hypertrophic
Leigh syndrome associated with a novel mutation in the COX15 gene.
Cardiomyopathy, Hypertrophic
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency.
Cardiomyopathy, Hypertrophic
Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy.
Cytochrome-c Oxidase Deficiency
Defects in the biosynthesis of mitochondrial heme c and heme a in yeast and mammals.
Cytochrome-c Oxidase Deficiency
Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy.
Cytochrome-c Oxidase Deficiency
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency.
Leigh Disease
Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into its Function in Eukaryotes.
Leigh Disease
Functional and genetic studies demonstrate that mutation in the COX15 gene can cause Leigh syndrome.
Leigh Disease
Leigh syndrome associated with a novel mutation in the COX15 gene.
Leigh Disease
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency.
Leigh Disease
Novel mutations in COX15 in a long surviving Leigh syndrome patient with cytochrome c oxidase deficiency.
Leigh Disease
Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome.
Lung Neoplasms
Cox15 is a novel oncogene that required for lung cancer cell proliferation.
Mitochondrial Diseases
Phenotypic variability and mutation hotspot in COX15-related Leigh syndrome.
Neoplasms
Cox15 is a novel oncogene that required for lung cancer cell proliferation.
Neoplasms
Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
Nervous System Diseases
Analysis of Oligomerization Properties of Heme a Synthase Provides Insights into its Function in Eukaryotes.
Osteoporosis
Identification of B cells participated in the mechanism of postmenopausal women osteoporosis using microarray analysis.
Pulmonary Disease, Chronic Obstructive
Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease.
Starvation
CtaA of Staphylococcus aureus is required for starvation survival, recovery, and cytochrome biosynthesis.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction

cox15 mutants are blocked in heme A but not heme O biosynthesis
malfunction
overexpression of a non-functional mutant causes a reduction in heme A content. This hindrance in the heme A synthesis provokes a reduction on CcO activity and, in consequence, an impairment on Trypanosoma cruzi survival, proliferation and infectivity
malfunction
-
overexpression of a non-functional mutant causes a reduction in heme A content. This hindrance in the heme A synthesis provokes a reduction on CcO activity and, in consequence, an impairment on Trypanosoma cruzi survival, proliferation and infectivity
-
metabolism

-
heme O hydroxylation, catalyzed by Cox15p is an important regulatory step
metabolism
-
the enzyme is involved in biosynthesis of heme A
metabolism
-
the enzyme is involved in biosynthesis of heme A
metabolism
the enzyme is involved in biosynthesis of heme A
metabolism
the enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
metabolism
-
the enzyme is involved in heme A biosynthesis
metabolism
-
the enzyme is required for heme A biosynthesis
metabolism
the enzyme is required for heme A biosynthesis
metabolism
-
the enzyme is involved in biosynthesis of heme A, an obligatory cofactor in eukaryotic cytochrome c oxidase. The enzyme catalyses the conversion of heme o to heme a by two successive hydroxylations of the methyl group at C-8, using water as the oxygen source. The first hydroxylation forms heme i, the second hydroxylation results in an unstable dihydroxymethyl group, which spontaneously dehydrates, resulting in the formyl group of heme a
-
metabolism
-
the enzyme is involved in biosynthesis of heme A
-
metabolism
-
the enzyme is required for heme A biosynthesis
-
physiological function

the COX15 protein is essential for the assembly of yeast cytochrome oxidase
physiological function
the enzyme is required for starvation survival, recovery, and cytochrome biosynthesis
physiological function
-
the enzyme is required for starvation survival, recovery, and cytochrome biosynthesis
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
DELTA211-217
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
E57A
heme content of the mutant enzyme is 62% compared to wild-type enzyme
E57A/H216A
heme content of the mutant enzyme is 28% compared to wild-type enzyme
E57A/H278A
heme content of the mutant enzyme is 42% compared to wild-type enzyme
E57Q
heme content of the mutant enzyme is 65% compared to wild-type enzyme
H123A
heme content of the mutant enzyme is 74% compared to wild-type enzyme
H123Q
heme content of the mutant enzyme is 64% compared to wild-type enzyme
H216A
heme content of the mutant enzyme is 22% compared to wild-type enzyme
H216A-H278A
heme content of the mutant enzyme is 5% compared to wild-type enzyme
H216L
no detectable activity
H216M/DELTA211-217
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
H216Q
heme content of the mutant enzyme is 33% compared to wild-type enzyme
H216Q-H278Q
heme content of the mutant enzyme is 6% compared to wild-type enzyme
H278A
heme content of the mutant enzyme is 56% compared to wild-type enzyme
H278C
heme content of the mutant enzyme is 14% compared to wild-type enzyme
H278Q
heme content of the mutant enzyme is 15% compared to wild-type enzyme
H60A
heme content of the mutant enzyme is 74% compared to wild-type enzyme
H60A/H123A
heme content of the mutant enzyme is 88% compared to wild-type enzyme
H60L
no detectable activity
H60Q
heme content of the mutant enzyme is 65% compared to wild-type enzyme
H60Q-H123Q
heme content of the mutant enzyme is 83% compared to wild-type enzyme
Q103A
heme content of the mutant enzyme is 82% compared to wild-type enzyme
Q257A
heme content of the mutant enzyme is 78% compared to wild-type enzyme
R217A
heme content of the mutant enzyme is 84% compared to wild-type enzyme
R217Q
heme content of the mutant enzyme is 89% compared to wild-type enzyme
R61A
heme content of the mutant enzyme is 77% compared to wild-type enzyme
R61Q
heme content of the mutant enzyme is 79% compared to wild-type enzyme
W39A
heme content of the mutant enzyme is 84% compared to wild-type enzyme
DELTA211-217
-
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
-
E57A
-
heme content of the mutant enzyme is 62% compared to wild-type enzyme
-
H123A
-
heme content of the mutant enzyme is 74% compared to wild-type enzyme
-
H123L
-
inactive enzyme, stable proteins containing heme O and heme B
-
H123M
-
inactive enzyme, stable proteins containing heme O and heme B
-
H216L
-
no detectable activity
-
H216M/DELTA211-217
-
Bacillus subtilis LMT20R is deleted for the ctaA gene and, therefore, completely blocked in heme A synthesis. Plasmid pH216MS is obtained from plasmid pH216M (encoding the mutant CtaA-H216M) and carries a 21 bp deletion in ctaA. The CtaADELTA211-217 variant encoded by pH216MS is active in heme A synthesis and supports assembly of normal levels of cytochrome caa3
-
H278Q
-
heme content of the mutant enzyme is 15% compared to wild-type enzyme
-
H60A
-
heme content of the mutant enzyme is 74% compared to wild-type enzyme
-
H60L
-
no detectable activity
-
H60Q
-
heme content of the mutant enzyme is 65% compared to wild-type enzyme
-
R217W
-
mutations of COX15 causing single amino acid conversions associated with fatal infantile hypertrophic cardiomyopathy and the neurological disorder Leigh syndrome results in impaired catalytic function, and the mutation affects oligomeric properties of the enzyme. The mutations affects protein folding and heme binding
S344P
-
mutations of COX15 causing single amino acid conversions associated with fatal infantile hypertrophic cardiomyopathy and the neurological disorder Leigh syndrome results in impaired stability. The mutations affect protein folding and heme binding
H129A
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
H206A
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
H307A
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
H129A
-
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
-
H206A
-
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
-
H307A
-
overexpression of the non-functional TcCox15 mutants causes a negative effect over heme A synthesis, affecting the function of the CcO complex and proliferation of epimastigotes
-
additional information
-
mutations in COX15 repress heme O synthesis and have a dominant effect when combined with other mutations
C191A/C197A

low activity
C191A/C197A
the heme content is reduced to a half of the wild-type level
C35A/C42A

no detectable activity
C35A/C42A
heme content of the mutant enzyme is 77% compared to wild-type enzyme
H123L

no detectable activity
H123L
inactive enzyme, stable proteins containing heme O and heme B
H123M

no detectable activity
H123M
inactive enzyme, stable proteins containing heme O and heme B
H216M

low activity
H216M
heme content of the mutant enzyme is 37% compared to wild-type enzyme
H216M
the H216M variant binds the enzyme substrate heme O, probably with methionine as an axial ligand, but is defective in heme A synthesis and accumulates a mono-hydroxylated reaction intermediate, heme I
H216M
the variant has a decreased heme A synthase activity. It contains heme B, heme O, and heme I, as well as trace amounts of heme A
H278M

low activity
H278M
heme content of the mutant enzyme is 40% compared to wild-type enzyme
H60M

low activity
H60M
the mutant enzyme contains heme B and heme A at levels comparable to that of wild-type enzyme
H216M

-
the H216M variant binds the enzyme substrate heme O, probably with methionine as an axial ligand, but is defective in heme A synthesis and accumulates a mono-hydroxylated reaction intermediate, heme I
-
H216M
-
the variant has a decreased heme A synthase activity. It contains heme B, heme O, and heme I, as well as trace amounts of heme A
-
H60M

-
low activity
-
H60M
-
the mutant enzyme contains heme B and heme A at levels comparable to that of wild-type enzyme
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.